FDA Investigator Camille D Brown

Camille D Brown has inspections in 12 countries as of 04 Nov 2022. Camille D Brown has collaborated with a combinined 1877 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
100
Last Inspection Date:
04 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
100006424
Country:
United States of America, India, Spain, Poland, France, Hungary, Jordan, Italy, Canada, Australia, South Africa
Co-Investigator(s):
Adam C Hipko, Adrian Rodriguez, Alanna Lmussawwir Bias, Amanda J White, Andrace Lde Yampert, Andrea A Branche, Angela Mock, Arie R Dyk, Bing Lin, Brackens Harris, Brandi E Williams, Charles D Brown, Christopher D Rush, Christopher J Smith, Connie L Hannon Rabel, Corrine M Carter, Crystal S Harris Smith, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Daniel S Fam, Danny D Horner, Darla J Christopher, Deborah A Greco, Denise Connelly, Denise L Burosh, Elisa M Fleming, Ellen J Tave, Elmina E Akwo, Elvia J Cervantes, Fernando C Martinez, Gajendiran Mahadevan, PhD, Gatica, Gene R Gunn, Glasgow, Grant, Iris C Macinnes, Jacob W Reynolds, James H Robinson, Jamie M Bumpas, Jane M Broussard, Janet B Abt, Janete F Guardia, Janice M Hickok, Jeffrey R Wooley, Jennifer C Adams, Jennifer D Young, Jennifer Owens Dowdy, Joanne M Schlossin, Joel D Martinez, Johann M Fitch, Johnson, Jonathan A Womack, Joy L Ramsey, Keegan B Mixon, Kelly D Sheppard, Kelly J Pegg, Kenitra D Hewitt, Kip J Hanks, Kirsten S Tharp, Lauren E Skokan, Leighton K Ngai, Lisa R Jennings, Liza L Quiles, Lloyd D Payne, Lorie S Hannappel, Lourdes R Genera, Maira P Brading, Makini Cobourne Duval, PhD, Marc R Dickens, Marilyn S Babu, Mario Seminara, Mathew T Thomas, MD, Monique Rac Lester, Monique S Frazier, Myra K Casey, Nancy A Bellamy, Nicola M Fenty Stewart, Patrice S Hall, Patrick D Stone, MS, Paul E Frazier, Pauline N Logan, Payne, Peter R Lenahan, Phillip D Waldron, Rebecca C O Bryan, Rebecca T Davis, Rene R Ramirez, Rhonda L Dash, Rian L Pope, Robert T Lorenz, Ronald L Koller, Ronda R Loyd Jones, Ruben C Ayala, PharmD, Sam H Haidar, PhD, Scott B Laufenberg, Scott T Ballard, Shannon A Lowe, Sherri J Jackson, Shirley H Isbill, State Agency, Tamera H Hunt, Tawny L Colling, Toby Vern H Hill, Travis M Beard, Travis S Brown, Tricia S Martinez, William S Vitale, Yaw O Osei, Yoonyc, Young M Yoon

Camille D Brown's Documents

Publish Date Document Type Title
June, 2016 EIR ADGYL LIFESCIENCES PRIVATE LIMITED - EIR, 2016-06-03
November, 2015 FDA 483 Sparks Regional Medical Center - IRB - Form 483, 2015-11-20
March, 2018 FDA 483 Richard Dumas - Form 483, 2018-03-29
September, 2015 EIR Shreyaskumar R. Patel, MD - EIR, 2015-09-30
May, 2019 FDA 483 Michael A. Shiekh, M.D. - Form 483, 2019-05-07
August, 2017 EIR Synexus US - EIR, 2017-08-10
May, 2018 FDA 483 Jose Fernando Mandujano, M.D. - Form 483, 2018-05-14
April, 2015 FDA 483 Dr. Peter Szmuk - Form 483, 2015-04-17
December, 2019 FDA 483 Phyllis J. Gee, M.D. - Form 483, 2019-12-17
February, 2019 FDA 483 Aukstuolis, Jim G., MD - Form 483, 2019-02-01
July, 2018 FDA 483 Canadas, Rafael M.D. - Form 483, 2018-07-16
January, 2019 FDA 483 Madhukar H. Trivedi, MD - Form 483, 2019-01-11
September, 2015 FDA 483 Shreyaskumar R. Patel, MD - Form 483, 2015-09-30
August, 2019 EIR Esperion - EIR, 2019-08-09
February, 2020 FDA 483 Richard D. Guyer, MD - Form 483, 2020-02-10
May, 2018 FDA 483 Michael J. Downing, M.D. - Form 483, 2018-05-30
November, 2015 EIR Sparks Regional Medical Center - IRB - EIR, 2015-11-20
August, 2019 FDA 483 David Gerber, M.D. - Form 483, 2019-08-19
August, 2019 FDA 483 Esperion - Form 483, 2019-08-09
June, 2019 FDA 483 University of Texas at Arlington IRB - Form 483, 2019-06-11
November, 2015 FDA 483 Response Sparks Regional Medical Center - IRB - Form 483R, 2015-12-07
March, 2018 FDA 483 Richard Dumas - Form 483, 2018-03-29

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more